gossamerbio
gossamerbio.com
About
Seralutinib is an inhaled PDGFRα/β, CSF1R, and c-KIT inhibitor developed for delivery via dry powder inhaler, aimed at the potential treatment of pulmonary arterial hypertension (PAH).
PWA Quality
Mobile optimization
70
Install experience
57
Offline support
0
User experience
80
Overall score
52
Was this app helpful?
App Info
- CategoryDesign
- Developergossamerbio.com
- AddedJune 30, 2026
- PWA SupportNot Supported
